MSPU des 3 provinces
Champlitte, Franche-comté, France
Location contact
José-Philippe MORENO, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07639554
The goal of this randomized trial is to assess the effectiveness of a targeted telephone reminder strategy, implemented by the patient's general practitioner, in enhancing participation in colorectal cancer screening among individuals who are not up to date . The participants are patients between 50 to 74 years old as they are the target for colorectal cancer screening. The main questions are:
* What is the percentage of patients who completed the colorectal cancer screening test during the intervention year , within the patient population of general practitioners participating in the study and identified as non-up-to-date for their screening status ? * Identifying potential factors influencing the effectiveness of the intervention based on various characteristics of the patient, the geographical area, the general practitioner, and the caller
Researchers will compare with other patients who are not up to date without the intervention of their general practionner with a telephone reminder.
Trial opening soon.
Get Notified50 year–74 year
All sexes
Interventional
Not applicable
Champlitte, Franche-comté, France
José-Philippe MORENO, MD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for general practionners :
Inclusion criteria
for patients :
Exclusion criteria
for general practionners:
Non inclusion Criteria for patients :
A telephone call will be made by a member of the patient's primary care team (general practitioner, medical secretary, public health nurse, or care coordinator), with priority given to a call by the patient's general practitioner. The call should preferably be made to the patient's mobile phone. If the call is unsuccessful, a voicemail message will be left, and a second call will be attempted within the following seven days. The voicemail message will include the name of the patient's general practitioner, the purpose of the call regarding colorectal cancer screening, and notification that a further attempt will be made to reach the patient. If the telephone exchange is successful, an appointment at the healthcare facility will be offered to the patient, during which the screening test will be offered to the patient, during which the screening test will be handed over and explained by one of the healthcare professionals from the same facility.
Time frame: 6 months after inclusion
Patients who completed the colorectal cancer screening test during the intervention year (year n), within the patient population of general practitioners participating in the study, and who were identified from the national health insurance list as not up to date with screening - a status that was confirmed by reviewing their medical records.
Completion of the screening will be confirmed by the presence of the test result in the patient's medical record within the General practionner's practice software, no later than three months after the end of the intervention.
This mesure will be done in each arm.
Time frame: 1 year after enrollment
Patients whose colorectal cancer screening status changed between the list received from National Health in year n and the list received in year n+1.
A change in status will be confirmed by the absence of the patient from the n+1 list, among those still registered within the general practitioner's patient panel.
Time frame: 3 months after the end of enrollment
Patients who completed the colorectal cancer screening (CRC) test during the intervention year , within the patient population of general practitioners participating in the study, and who were identified from the national health insurance list as not up to date with screening. This proportion will be analysed according to the following stratification variables:
Time frame: 3 months after the end of enrollment
In both study arms, identification of patients incorrectly included in the national health insurance list (i.e. patients already up to date with screening, those excluded from CRC screening, those under or awaiting colonoscopic follow-up, or currently undergoing treatment for colorectal cancer).
For the intervention arm, classification of all patients according to the following outcomes:
Time frame: 3 months after the end of the enrollment
In the intervention arm, time spent on all stages of the intervention:
Contact information is provided by the study sponsor or research team.
MSPU des 3 Provinces
Other
Optimizing Participation In Colorectal Cancer Screening By Direct Invitation Of Non Responders By General Practitionners: A Randomized Controlled Cluster Trial
Acronym: OPTIDEC COLO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07522177
Colorectal Cancer Screening
Stanford, California, United States
View Trial DetailsNCT07183046
Colorectal Cancer Screening, Fecal Immunochemical Test
Lebanon, New Hampshire, United States
View Trial DetailsNCT07606963
Colonic Diseases, Colonoscopy
Tychy, Silesian Voivodeship, Poland
View Trial DetailsNCT07541105
Breast Cancer Screening, Breast Diseases
View Trial Details